Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Drug Discovery Today|February 6, 2021
Targeting protein self-association in drug designLéopold Thabault, Maxime Liberelle, Raphaël Frédérick
Trends in Pharmacological Sciences|May 26, 2024
Emerging paradigms and recent progress in targeting ErbB in cancersNicolas Stoup, Maxime Liberelle, Nicolas Lebègue, et al.
Journal of Medicinal Chemistry|February 7, 2020
EGF-Containing Membrane-Bound Mucins: A Hidden ErbB2 Targeting Pathway?Maxime Liberelle, Nicolas Jonckheere, Patricia Melnyk, et al.
Journal of Pineal Research|December 26, 2023
Melatonin facts: Lack of evidence that melatonin is a radical scavenger in living systemsJean A Boutin, Maxime Liberelle, Saïd Yous, et al.
Molecules (Basel, Switzerland)|June 12, 2026
Imidazole-Based AT<sub>1</sub> Receptor Ligands: Design, Synthesis and Pharmacological EvaluationFlorian Descamps, Marouane Rami, Jean-François Goossens, et al.
Expert Opinion on Therapeutic Patents|July 18, 2024
Leucine-rich repeat kinase 2 (LRRK2) inhibitors for Parkinson's disease: a patent review of the literature to dateMargaux Morez, Antonio Jesús Lara Ordóñez, Patricia Melnyk, et al.
European Journal of Medicinal Chemistry|November 7, 2025
Functionalized nitrogen- and chalcogen-containing heterocyclic compounds as aromatase inhibitors: Design, synthesis and biological evaluationChang Ha Park, Marc Le Borgne, Marouan Rami, et al.
Journal of Medicinal Chemistry|April 7, 2022
Toward the Design of Ligands Selective for the C-Terminal Domain of TEADsMaxime Liberelle, Florine Toulotte, Nicolas Renault, et al.
European Journal of Medicinal Chemistry|January 25, 2022
Discovery of small molecules interacting at lactate dehydrogenases tetrameric interface using a biophysical screening cascadeLéopold Thabault, Chiara Brustenga, Perrine Savoyen, et al.
Pageof 3